A comparison of Breast Implant Illness-related symptoms between breast cancer survivors and breast augmentation recipients
Breast augmentation recipients report more BII-related symptoms than BC survivors with or without SBIs. These findings do not support the hypothesis that BII is a distinct disease entity mediated by a generic SBI-related pathogenesis that exists across different populations.Trial registration: This study was preregistered at ClinicalTrials.gov on June 2 nd 2022 (NCT05400954).
Authors
- Daphne de Jong (ORCID: https://orcid.org/0000-0002-9725-4060)
- F. van Leeuwen
- Marie-Jeanne TFD. Vrancken Peeters
- Mintsje de Boer (ORCID: https://orcid.org/0000-0001-7214-0713)
- Laura H. Zaal
- Hinne A. Rakhorst (ORCID: https://orcid.org/0000-0002-1663-6092)
- Marc AM Mureau
- Jonathan Spoor (ORCID: https://orcid.org/0000-0003-1183-4775)
- Eveline M.A. Bleiker
- Yvonne L.J. Vissers
Institutions
- Leiden University (NL)
- Maastricht University Medical Centre (NL)
- Medisch Spectrum Twente (NL)
- The Netherlands Cancer Institute (NL)
- Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NL)
- Zuyderland Medisch Centrum (NL)
- Ziekenhuis Groep Twente (NL)
- Erasmus MC Cancer Institute (NL)
- Amsterdam University Medical Centers (NL)
Publication Details
- Journal
- Plastic & Reconstructive Surgery
- Published
- 2026-03-27
- DOI
- https://doi.org/10.1097/prs.0000000000013061
- Primary Topic
- Breast Implant and Reconstruction
- Type
- article
- Field-Weighted Citation Impact
- 0.00